.
Intel

Intro To An IRO: Melissa Trombetta, Mylan .

Nasdaq Corporate Solutions highlights the Investor Relations Officers who perform beyond the traditional role of the IRO.

Intro To An IRO: Melissa Trombetta, Mylan

Null

Melissa Trombetta is Head of Global Investor Relations at Mylan N.V., a leading global pharmaceutical company whose differentiated business model focuses on access, durability and diversification. With more than 10 years of investor relations experience, Melissa joined the company in 2017 and brings to her current role investor communication expertise, a deep knowledge of the investor community and broad-based finance experience.

What are your top priorities and biggest challenges?

Since starting with Mylan in 2017, my top priorities have been learning the healthcare and pharmaceutical industries, as I came from the industrials world, while at the same time building relationships and credibility with my new partners in the investment community. 

Over the past decade, Mylan has prioritized its strategy of transforming our portfolio from a U.S. generics player to a diversified global pharmaceutical leader.   During our time of transformation, we were very focused on executing and performing and less focused on telling our story, which opened up the doors for others to do it for us.  So, one of my biggest challenges (and one of the most exciting parts of my role) is helping to own and evolve the Mylan narrative.  I believe Mylan is an extremely undervalued and underappreciated story, and it is my job to educate the Street on the long-term growth profile of the company.

How can the IRO best engage the investment community?

I know this may sound old school, but I would say that the best way to engage with the community is to pick up the phone, meet face-to-face, and establish a rapport.  We are all so busy and inundated with emails and constant news flow that I think establishing that personal relationship is critical and somewhat unique these days. 

I would also say it is critical to tell your story in a clear, concise and compelling way.  The investors that you are trying to attract are tracking dozens of other companies, so if your story is complex, it will be harder to get their attention and their capital.  Having that insight has helped to focus my efforts on breaking down our story into more digestible pieces, making it easier to engage with targeted investors and for investors to make more informed investment decisions. 

What is one important initiative that you’ve championed or experience that you’ve had as an IRO?

One of the first things I did when I joined Mylan was to bring in the Nasdaq Targeting team.  C-suite time is precious, so if I have a small window of opportunity to get the CEO, CFO or any of our business leaders in front of investors, I want to make sure I am maximizing the benefits of their time. Having those insights from the Targeting tool is more efficient and has put our leadership team in front of the right people.  In a short period of time, we have already started to see a shift in our investor base which is more aligned with the long-term strategy and mission of the company. 

What resources do you rely on to stay up to date on the capital markets?

I rely on the headlines and news feeds I receive internally as well as externally. I also rely on our Nasdaq Surveillance analyst who provides up-to-date information to ensure that I’m on top of current events and understand what’s being said about our industry, our competitors or Mylan specifically.  As a small team, having another set of eyes and ears to make sure that I understand what is relevant and moving the market is critical.

What advice do you have for the next generation of IRO?

I would say that relationships matter and are critical to establishing credibility in the marketplace. It’s important to pick up the phone, network and build those connections.  Just as important is understanding your company.  I don’t mean just the financials and products.  I mean, take the time to understand the values, the mission, and how it is perceived by all stakeholders. Mylan’s unique culture, for example, is one of the strongest selling points I try to weave into my conversations with people about our company. We’re not shy about what it takes to create long-term value, and the commitment it takes to get there. These insights help shape your messaging, make you a better communicator and as a result, attract the right investors. 

What skills do you think can make you successful?

I often say that being in Investor Relations is the best job I have ever had, and if I ever had to leave it, I would go kicking and screaming.  As an IR leader, the liaison between the company and the Street, I sit in such a unique vantage point at Mylan.  From an internal perspective, I have access to our operations, our commercial teams, our finance organization, our C-Suite and our board of directors.  Very often when people travel down their professional career path, they tend to stay the course in one, maybe two functional areas, but in Investor Relations, I have exposure to all functions which provides me with a more comprehensive view of the company.   From an external perspective, I am the main contact for the investment community, so I receive that critical feedback of the company on a real-time basis.  When my internal and external worlds come together, it energizes all parts of my brain.  At any moment, I may need to think on my feet, analyze information, listen, collaborate, communicate, be decisive, be creative, problem-solve, and more often than not, I need to do all of these things at the same time.   While this role may not be for everyone, I personally have found my niche. 


About Mylan

Mylan is a global pharmaceutical company committed to providing 7 billion people access to high quality medicine. We offer a growing portfolio of more than 7,500 marketed products in more than 165 countries and territories. We are one of the world's largest producers of active pharmaceutical ingredients. Every member of our approximately 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more about how Mylan is built to last and positioned for growth at investor.mylan.com.

Follow us:

Twitter: https://twitter.com/MylanNews

LinkedIn: https://www.linkedin.com/company/mylan/

YouTube: https://www.youtube.com/user/SeeInsideMylan

Learn more:

Mylan IR: http://investor.mylan.com/investor-relations

Mylan Better Health: https://mylanbetterhealth.com


ABOUT NASDAQ IR SOLUTIONS

NASDAQ IR INSIGHT | ADVISORY SERVICES | STRATEGIC CAPITAL INTELLIGENCE | PERCEPTION STUDIES

Designed for companies of all sizes and at every stage of the corporate lifecycle, our full suite delivers comprehensive content with innovative technology tools in an integrated IR workflow.

Nasdaq IR Solutions offers a suite of IR content, analytics and advisory services to help investor relations professionals:

  • Gain insight into market developments and institutional investor activities.
  • Understand investor opportunities and risks.
  • Define and prioritize outreach.
  • Measure the impact of your IR program.

This communication and the content found by following any link herein are being provided to you by Nasdaq Corporate Solutions, a business of Nasdaq, Inc. and certain of its subsidiaries (collectively, “Nasdaq”), for informational purposes only. Nasdaq makes no representation or warranty with respect to this communication or such content and expressly disclaims any implied warranty under law. Nasdaq, the Nasdaq logo, and Nasdaq Corporate Solutions are registered and unregistered trademarks, or service marks, of Nasdaq, Inc. or its subsidiaries in the U.S. and other countries. ©Nasdaq, Inc. 2018. All rights reserved.Comments or opinions expressed on the blog are those of their respective contributors only. The views expressed on this blog do not necessarily represent the views of Nasdaq, Inc. or any of its affiliates, or its or their management or employees (collectively, “Nasdaq”). Nasdaq is not responsible for, and disclaims any and all liability for the content contributed by contributors to the blog.


This communication and the content found by following any link herein are being provided to you by Nasdaq Corporate Solutions, a business of Nasdaq, Inc. and certain of its subsidiaries (collectively, “Nasdaq”), for informational purposes only. Nasdaq makes no representation or warranty with respect to this communication or such content and expressly disclaims any implied warranty under law. Nasdaq, the Nasdaq logo, and Nasdaq Corporate Solutions are registered and unregistered trademarks, or service marks, of Nasdaq, Inc. or its subsidiaries in the U.S. and other countries. ©Nasdaq, Inc. 2018. All rights reserved.

Comments or opinions expressed on the blog are those of their respective contributors only. The views expressed on this blog do not necessarily represent the views of Nasdaq, Inc. or any of its affiliates, or its or their management or employees (collectively, “Nasdaq”). Nasdaq is not responsible for, and disclaims any and all liability for the content contributed by contributors to the blog.

Learn how IROs stay ahead of the curve:

Recent posts{{catTitle ? " in " + catTitle : ""}}
{{post.Date | date:'MMM d'}}
Scroll up